Mealey's (December 2, 2022, 1:09 PM EST) -- TRENTON, N.J. — Following a bench trial, a federal judge in New Jersey on Dec. 1 ruled in favor of Bausch Health Ireland Limited, Bausch Health Americas Inc. and Bausch Health US LLC (Bausch, collectively) with regard to a generic drug makers’ assertion that four patents associated with the Bausch plaque psoriasis treatments Duobrii and Bryhali are invalid as obvious....